<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">J. Abdom. Wall Surg.</journal-id>
<journal-title-group>
<journal-title>Journal of Abdominal Wall Surgery</journal-title>
<abbrev-journal-title abbrev-type="pubmed">J. Abdom. Wall Surg.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2813-2092</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">17769</article-id>
<article-id pub-id-type="doi">10.3389/jaws.2026.17769</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Shouldice versus Lichtenstein repair for recurrent groin hernia following laparo-endoscopic repair: a propensity score&#x2013;matched analysis of the herniamed registry</article-title>
<alt-title alt-title-type="left-running-head">Lorenz et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/jaws.2026.17769">10.3389/jaws.2026.17769</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Lorenz</surname>
<given-names>R.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/242504"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Arand</surname>
<given-names>S.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3694964"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Conze</surname>
<given-names>J.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fortelny</surname>
<given-names>R.</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/129086"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kilk</surname>
<given-names>K.</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Koch</surname>
<given-names>A.</given-names>
</name>
<xref ref-type="aff" rid="aff9">
<sup>9</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>K&#xf6;ckerling</surname>
<given-names>F.</given-names>
</name>
<xref ref-type="aff" rid="aff10">
<sup>10</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/124616"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mayer</surname>
<given-names>F.</given-names>
</name>
<xref ref-type="aff" rid="aff11">
<sup>11</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/229297"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pokorny</surname>
<given-names>H.</given-names>
</name>
<xref ref-type="aff" rid="aff12">
<sup>12</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Riediger</surname>
<given-names>H.</given-names>
</name>
<xref ref-type="aff" rid="aff10">
<sup>10</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2613897"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wiese</surname>
<given-names>M.</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1503202"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hukauf</surname>
<given-names>M.</given-names>
</name>
<xref ref-type="aff" rid="aff13">
<sup>13</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wiessner</surname>
<given-names>R.</given-names>
</name>
<xref ref-type="aff" rid="aff14">
<sup>14</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/468813"/>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>
<institution>Hernia Center 3&#x2b;CHIRURGEN</institution>, <city>Berlin</city>, <country country="DE">Germany</country>
</aff>
<aff id="aff2">
<label>2</label>
<institution>Department of General and Abdominal Surgery, Clinic for General and Abdominal Surgery, University Hospital Brandenburg an der Havel</institution>, <city>Hochstrasse</city>, <country country="DE">Germany</country>
</aff>
<aff id="aff3">
<label>3</label>
<institution>Department of General and Abdominal Surgery, Ernst von Bergmann Hospital Potsdam</institution>, <city>Potsdam</city>, <country country="DE">Germany</country>
</aff>
<aff id="aff4">
<label>4</label>
<institution>UM Hernienzentrum Dr. Conze</institution>, <city>M&#xfc;nchen</city>, <country country="DE">Germany</country>
</aff>
<aff id="aff5">
<label>5</label>
<institution>Department of General, Visceral, Pediatric and Transplant Surgery, University Hospital Aachen</institution>, <city>Aachen</city>, <country country="DE">Germany</country>
</aff>
<aff id="aff6">
<label>6</label>
<institution>Department of General Surgery, Klinik Ottakring</institution>, <city>Vienna</city>, <country country="AT">Austria</country>
</aff>
<aff id="aff7">
<label>7</label>
<institution>Medical Faculty, Sigmund Freud University</institution>, <city>Vienna</city>, <country country="AT">Austria</country>
</aff>
<aff id="aff8">
<label>8</label>
<institution>Hernia Center Kelkheim, Rhein-Main Martin G. Wiese</institution>, <city>Kelkheim</city>, <country country="DE">Germany</country>
</aff>
<aff id="aff9">
<label>9</label>
<institution>Hernia Center Dr. Andreas Koch</institution>, <city>Cottbus</city>, <country country="DE">Germany</country>
</aff>
<aff id="aff10">
<label>10</label>
<institution>Hernia Center, Vivantes Humboldt Hospital, Academic Teaching Hospital of Charit&#xe9;, University Medicine</institution>, <city>Berlin</city>, <country country="DE">Germany</country>
</aff>
<aff id="aff11">
<label>11</label>
<institution>Department of Surgery, University Hospital, Paracelsus Medical University</institution>, <city>Salzburg</city>, <country country="AT">Austria</country>
</aff>
<aff id="aff12">
<label>12</label>
<institution>Franziskus Spital Margareten</institution>, <city>Wien</city>, <country country="AT">Austria</country>
</aff>
<aff id="aff13">
<label>13</label>
<institution>StatConsult GmbH</institution>, <city>Magdeburg</city>, <country country="DE">Germany</country>
</aff>
<aff id="aff14">
<label>14</label>
<institution>Department of General and Visceral Surgery, Kardinal Schwarzenberg Klinikum</institution>, <city>Pongau</city>, <country country="AT">Austria</country>
</aff>
<author-notes>
<corresp id="c001">
<label>&#x2a;</label>Correspondence: R. Lorenz, <email xlink:href="mailto:lorenz@3chirurgen.de">lorenz@3chirurgen.de</email>
</corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-11-13">
<day>13</day>
<month>11</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>5</volume>
<elocation-id>17769</elocation-id>
<history>
<date date-type="received">
<day>04</day>
<month>09</month>
<year>2026</year>
</date>
<date date-type="rev-recd">
<day>23</day>
<month>10</month>
<year>2026</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>11</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Lorenz, Arand, Conze, Fortelny, Kilk, Koch, K&#xf6;ckerling, Mayer, Pokorny, Riediger, Wiese, Hukauf and Wiessner.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Lorenz, Arand, Conze, Fortelny, Kilk, Koch, K&#xf6;ckerling, Mayer, Pokorny, Riediger, Wiese, Hukauf and Wiessner</copyright-holder>
<license>
<ali:license_ref start_date="2026-11-13">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>International guidelines recommend an anterior mesh-based Lichtenstein repair for recurrent groin hernias following previous laparo-endoscopic repair. Whether the mesh-free Shouldice technique provides comparable outcomes in this setting remains unknown. This study compared perioperative and one-year outcomes after Shouldice and Lichtenstein repair using data from the Herniamed Registry.</p>
</sec>
<sec>
<title>Methods</title>
<p>Adult patients undergoing elective repair of a first unilateral recurrent groin hernia after previous laparo-endoscopic repair were identified from the Herniamed Registry. Patients treated with either Shouldice or Lichtenstein repair and with complete one-year follow-up were eligible. A 1:1 propensity score matching was performed using demographic, clinical, hernia-related, and operative variables to minimize baseline differences. All outcome variables such as intraoperative, postoperative and general complications, complication-related reoperations, surgical site complications, hernia recurrence at 1&#xa0;year and patient-reported pain outcomes at 1&#xa0;year were analysed in this study.</p>
</sec>
<sec>
<title>Results</title>
<p>Of 12,498 eligible patients, 253 underwent Shouldice repair and 12,245 underwent Lichtenstein repair. Propensity score matching yielded 248 well-balanced patient pairs. No significant differences were observed between the two procedures regarding one-year recurrence, intraoperative or postoperative complications, complication-related reoperations, postoperative haemorrhage, seroma, surgical-site infection, or patient-reported pain outcomes after adjustment for multiple testing. Pain on exertion at 1&#xa0;year was reported less frequently after Shouldice repair than after Lichtenstein repair (18.5% vs. 27.0%; <italic>P</italic>&#x3d;0.031), although this difference did not remain statistically significant after Bonferroni correction.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>In this propensity score&#x2013;matched registry analysis, no statistically significant differences in perioperative and one-year outcomes were detected between Shouldice repair and guideline-recommended Lichtenstein repair for first recurrent groin hernias following previous laparo-endoscopic repair. Given the small number of Shouldice procedures and the wide confidence intervals, clinically relevant differences cannot be excluded. In carefully selected patients and when performed by experienced surgeons, the Shouldice technique may nevertheless represent a mesh-free option. Larger comparative studies with long-term follow-up are required to confirm these findings and further define its role in the management of recurrent groin hernia.</p>
</sec>
</abstract>
<kwd-group>
<kwd>database study</kwd>
<kwd>groin hernias</kwd>
<kwd>Lichtenstein</kwd>
<kwd>recurrent inguinal hernia</kwd>
<kwd>Shouldice</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. FK declare that the Herniamed Database received funding from Johnson&#x26;Johnson, Norderstedt, Karl Storz, Tuttlingen, MenkeMed, Munich, DB Karlsruhe, PFM Medical, Cologne, Medtronic, Meerbusch and personal fees from BD Karlsruhe. The funders were not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.</funding-statement>
</funding-group>
<counts>
<fig-count count="3"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="19"/>
<page-count count="11"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Despite the widespread adoption of mesh-based techniques over the past 3&#xa0;decades, recurrent groin hernia remains a significant clinical challenge. Alongside chronic postoperative pain, recurrence continues to represent one of the most important adverse outcomes following groin hernia repair [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>]. Data from several national hernia registries consistently demonstrate that approximately 10% of groin hernia operations are performed for recurrence, a proportion that has remained remarkably stable over time [<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>]. Moreover, recurrent groin hernias may present many years after the index operation, underscoring the importance of long-term follow-up when evaluating treatment outcomes [<xref ref-type="bibr" rid="B5">5</xref>]. The mechanisms underlying hernia recurrence are multifactorial and remain incompletely understood. In addition to technical failure, impaired connective tissue integrity, biological predisposition, and mesh-related factors have all been implicated [<xref ref-type="bibr" rid="B5">5</xref>].</p>
<p>The management of recurrent groin hernia is guided by the principle of changing the surgical plane (&#x201c;<italic>vice versa</italic>&#x201d; principle), which is strongly endorsed by current international guidelines [<xref ref-type="bibr" rid="B6">6</xref>]. Consequently, an open anterior repair is recommended for recurrence following a previous laparo-endoscopic repair, whereas a posterior laparo-endoscopic approach is advised after failure of a previous open repair [<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>]. Accordingly, Lichtenstein repair remains the guideline-recommended procedure for recurrent groin hernias after prior laparo-endoscopic repair.</p>
<p>Comparative studies of the Shouldice and Lichtenstein techniques have shown that tissue-based repair is associated with a modestly higher recurrence [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>]. Evidence regarding chronic postoperative pain is inconsistent: one meta-analysis reported a lower risk of chronic pain after Shouldice repair [<xref ref-type="bibr" rid="B9">9</xref>], whereas another found no significant difference [<xref ref-type="bibr" rid="B8">8</xref>]. Nevertheless, in carefully selected patients, tissue repair without implantation of an additional mesh may represent an attractive alternative, particularly after previous posterior mesh placement. Interest in tissue-based techniques, especially the standardized Shouldice repair, has therefore increased in recent years. Current evidence and the updated international guidelines identify the Shouldice technique as the preferred tissue-based repair whenever a non-mesh approach is indicated [<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B10">10</xref>]. This recommendation is supported by high-quality long-term outcome data and the exceptional degree of procedural standardization achieved by the Shouldice technique [<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>].</p>
<p>This registry-based propensity score&#x2013;matched study compared perioperative and one-year outcomes following Shouldice and Lichtenstein repair for recurrent groin hernias after previous laparo-endoscopic repair. All outcome parameters such as intraoperative, postoperative and general complications, complication-related reoperations, surgical site complications, hernia recurrence at 1&#xa0;year and patient-reported pain outcomes at 1&#xa0;year were analysed in this study.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and methods</title>
<sec id="s2-1">
<title>Herniamed registry</title>
<p>The Herniamed Registry is a multicentre, internet-based quality assurance and outcomes registry established in 2009 to prospectively document hernia surgery and facilitate clinical outcomes research [<xref ref-type="bibr" rid="B13">13</xref>]. At the time of the present analysis, 1,088 hospitals and surgical practices in Germany, Austria, and Switzerland were contributing data.</p>
<p>Written informed consent was obtained from all participants before inclusion in the registry. Patients were instructed to report postoperative complications to the treating institution, where additional clinical evaluation was performed if indicated. Standardized follow-up questionnaires are distributed by the treating hospital or surgeon to both patients and their general practitioners at 1, 5, and 10 years after surgery. These questionnaires document further postoperative complications, recurrence, pain at rest, pain on exertion, and chronic pain requiring treatment. Recurrence, pain at rest, pain on exertion, and pain requiring treatment were recorded as reported in the standardized 1-year follow-up questionnaires by the patient and/or the general practitioner, with clinical examination if indicated. Smoking was documented in the registry as a binary variable (yes/no); current, former, and occasional smoking cannot be distinguished.</p>
<p>The Herniamed Registry has received ethical approval from the Ethics Committee of the Canton of St. Gallen (BASEC No. 2016-00123), the Ethics Committee of the University of T&#xfc;bingen (287/2017 BO2), the Ethics Committee of the State Medical Association of Baden-W&#xfc;rttemberg (F-2022-111), and the Ethics Committee of the University of Cologne (24-1115-retro).</p>
</sec>
<sec id="s2-2">
<title>Study population</title>
<p>Patients were identified from the Herniamed Registry according to predefined eligibility criteria. Eligible patients fulfilled all of the following criteria:<list list-type="simple">
<list-item>
<label>&#x2212;</label>
<p>groin hernia repair;</p>
</list-item>
<list-item>
<label>&#x2212;</label>
<p>the patient master data as well as the procedure-related data have the entry-state key &#x201c;complete&#x201d;, i.e., only completely documented cases regarding the mandatory entries;</p>
</list-item>
<list-item>
<label>&#x2212;</label>
<p>unilateral repair;</p>
</list-item>
<list-item>
<label>&#x2212;</label>
<p>first recurrent groin hernia following previous laparo-endoscopic repair;</p>
</list-item>
<list-item>
<label>&#x2212;</label>
<p>age &#x2265;18 years;</p>
</list-item>
<list-item>
<label>&#x2212;</label>
<p>elective surgery;</p>
</list-item>
<list-item>
<label>&#x2212;</label>
<p>EHS classification limited to medial, lateral, femoral, or combined defects (scrotal hernias excluded);</p>
</list-item>
<list-item>
<label>&#x2212;</label>
<p>repair using either the Shouldice (non-mesh) or Lichtenstein (mesh-based) technique;</p>
</list-item>
<list-item>
<label>&#x2212;</label>
<p>approved mesh implantation for Lichtenstein repair (Physiomesh excluded);</p>
</list-item>
<list-item>
<label>&#x2212;</label>
<p>operation date up to and including April 30, 2025 (later operations only if 1-year follow-up information was already available); and</p>
</list-item>
<list-item>
<label>&#x2212;</label>
<p>complete documentation of 1-year follow-up with completely documented visit.</p>
</list-item>
</list>
</p>
<p>Following application of all eligibility criteria and data plausibility checks, 12,498 patients formed the eligible study cohort (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Flowchart of patient inclusion.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="jaws-05-17769-g001.tif">
<alt-text content-type="machine-generated">Flowchart illustrating the selection and exclusion process for recurrent unilateral inguinal hernia repairs, starting from 1,650,763 hernia operations to 12,498 fully documented cases, with exclusion criteria and corresponding percentages at each step.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2-3">
<title>Statistical analysis</title>
<p>All analyses were performed with the software SAS 9.4 (SAS Institute Inc., Cary, NC, USA). The univariate analyses describing the patient population were deliberately conducted at the full significance level of 5% for exploratory purposes. The analyses of the twelve outcome variables were Bonferroni-adjusted to account for multiple testing, i.e., only p-values of p &#x2264; 0.00417 (0.05/12) were considered significant. The estimation of the odds ratio for paired samples was performed analogously, with a confidence interval adjusted according to the significance level of alpha &#x3d; 0.00417.</p>
<p>After checking the plausibility and inclusion criteria, pairwise comparisons were conducted for analysis of patients with Shouldice and Lichtenstein. The following steps were taken:</p>
<p>Univariate analysis of the patient population was first performed with regard to the matching parameters&#x2013;for exploratory purposes only. For unadjusted homogeneity tests of the OP technique, the chi-square test and the robust t-test (Satterthwaite) were used for categorical and continuous variables, respectively, whereby analysis of non-normal distributed data (mesh size) was conducted on log-transformed values.</p>
<p>For comparisons taking into account potential confounders, a propensity score matching was performed: pairs of hernia repairs with Shouldice and Lichtenstein were matched in a 1:1 propensity score matching using a robust greedy algorithm and a caliper of 0.2 standard deviations of the logit of the propensity score. The propensity score model included the following matching variables, which were a-priori selected based on their clinical relevance:<list list-type="simple">
<list-item>
<label>&#x2212;</label>
<p>Age (in years)</p>
</list-item>
<list-item>
<label>&#x2212;</label>
<p>ASA score [I, II, III-IV]</p>
</list-item>
<list-item>
<label>&#x2212;</label>
<p>EHS classification [medial, femoral, lateral, combined]</p>
</list-item>
<list-item>
<label>&#x2212;</label>
<p>Preoperative pain [yes, no, unknown]</p>
</list-item>
<list-item>
<label>&#x2212;</label>
<p>COPD [yes, no]</p>
</list-item>
<list-item>
<label>&#x2212;</label>
<p>Diabetes mellitus [yes, no]</p>
</list-item>
<list-item>
<label>&#x2212;</label>
<p>Aortic aneurysm [yes, no]</p>
</list-item>
<list-item>
<label>&#x2212;</label>
<p>Immunosuppression [yes, no]</p>
</list-item>
<list-item>
<label>&#x2212;</label>
<p>Corticoids [yes, no]</p>
</list-item>
<list-item>
<label>&#x2212;</label>
<p>Smoking [yes, no]</p>
</list-item>
<list-item>
<label>&#x2212;</label>
<p>Coagulopathy [yes, no]</p>
</list-item>
<list-item>
<label>&#x2212;</label>
<p>Anticoagulant medication [yes, no],</p>
</list-item>
<list-item>
<label>&#x2212;</label>
<p>Antithrombotic medication [yes, no],</p>
</list-item>
</list>
</p>
<p>In addition, sex [male, female], BMI [underweight, normal weight, overweight, obese/morbid], defect size [I (&#x3c;1.5&#xa0;cm), II (1.5&#x2013;3&#xa0;cm), III (&#x3e;3&#xa0;cm)] and timepoint of recurrence [&#x2264;2 years, 2&#x2013;10 years, &#x3e;10 years] were defined as exact matching variables, in which no variability was allowed between matched pairs. Matching variables were selected <italic>a priori</italic> on the basis of clinical plausibility as potential confounders of both treatment choice and outcome, irrespective of their univariable p-values.</p>
<p>Balancing of matching parameters before and after matching was quantified via standardized differences. As a rule of thumb, a good balance is assured for the variables included in the model with a standardized difference of less than 10% (&#x3c;0.1).</p>
<p>All outcome variables of the matched-pairs (Shouldice vs. Lichtenstein) such as intraoperative, postoperative and general complications, complication-related reoperations, surgical site complications, hernia recurrence at 1&#xa0;year, pain at rest, pain on exertion, pain requiring treatment, trocar hernia, secondary hemorrhage, seroma, and infection on 1-year follow-up were analysed in this study. For these categorical outcome variables, the exact McNemar test (test for systematic difference between paired patients) was performed, wherein the p-value must be interpreted in accordance with the significance level of 0.417%, Bonferroni-adjusted for multiple testing. As a conservative approach, the Bonferroni correction was applied to all twelve outcome variables. Further, results were quantified using the odds ratio for matched pairs with Bonferroni-adjusted confidence interval and additionally presented in a forest plot (<xref ref-type="sec" rid="s14">Supplementary Figure S1</xref>).</p>
<p>We assessed the reporting of this registry-based study against the STROBE guidelines and the RECORD extension for routinely collected health data. The completed RECORD checklist is provided as <xref ref-type="sec" rid="s14">Supplementary Table S1</xref>. Emergency procedures were excluded because incarceration, strangulation, or bowel compromise substantially influence perioperative outcomes independently of the repair technique. The age criterion refers to the patient&#x2019;s age at the time of the recurrent hernia repair under investigation.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Study population</title>
<p>Patient selection is illustrated in <xref ref-type="fig" rid="F1">Figure 1</xref>. After application of the predefined eligibility criteria and data plausibility checks, 12,498 patients formed the eligible study cohort. Of these, 253 patients (2.0%) underwent Shouldice repair and 12,245 (98.0%) underwent Lichtenstein repair. The matched outcome analysis comprised 248 pairs (n &#x3d; 496).</p>
</sec>
<sec id="s3-2">
<title>Baseline characteristics before matching</title>
<p>Baseline patient and hernia characteristics of selected cases before propensity score matching are summarized in <xref ref-type="table" rid="T1">Table 1</xref> and <xref ref-type="sec" rid="s14">Supplementary Table S2</xref>. Compared with patients undergoing Lichtenstein repair, those treated with Shouldice repair were significantly younger (57.6 &#xb1; 15.9 vs. 62.4 &#xb1; 13.3 years, <italic>P</italic> &#x3c; 0.001). Significant differences were also observed for sex, BMI, ASA classification, defect size, EHS classification, preoperative pain, overall prevalence of risk factors, and diabetes mellitus. No significant differences were found regarding the time to recurrence, COPD, smoking status, coagulopathy, immunosuppression, corticosteroid therapy, antithrombotic medication, anticoagulant medication, or aortic aneurysm.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Unadjusted analysis results for homogeneity between Shouldice vs. Lichtenstein for categorical variables before matching.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="2" align="left">&#x200b;</th>
<th colspan="4" align="left">OP technique</th>
<th align="left">&#x200b;</th>
</tr>
<tr>
<th colspan="2" align="left">&#x200b;</th>
<th colspan="2" align="left">Shouldice</th>
<th colspan="2" align="left">Lichtenstein</th>
<th align="left">&#x200b;</th>
</tr>
<tr>
<th align="left">&#x200b;</th>
<th align="left">&#x200b;</th>
<th align="left">N</th>
<th align="left">%</th>
<th align="left">N</th>
<th align="left">%</th>
<th align="left">p-Value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="2" align="left">Sex</td>
<td align="left">Male</td>
<td align="left">216</td>
<td align="left">85.4</td>
<td align="left">11,762</td>
<td align="left">96.1</td>
<td align="left">&#x3c;0.001</td>
</tr>
<tr>
<td align="left">Female</td>
<td align="left">37</td>
<td align="left">14.6</td>
<td align="left">483</td>
<td align="left">3.9</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td rowspan="4" align="left">BMI</td>
<td align="left">Underweight</td>
<td align="left">1</td>
<td align="left">0.4</td>
<td align="left">48</td>
<td align="left">0.4</td>
<td align="left">&#x3c;0.001</td>
</tr>
<tr>
<td align="left">Normal weight</td>
<td align="left">127</td>
<td align="left">50.4</td>
<td align="left">4616</td>
<td align="left">37.8</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td align="left">Overweight</td>
<td align="left">102</td>
<td align="left">40.5</td>
<td align="left">5922</td>
<td align="left">48.5</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td align="left">Obesity/Morbid</td>
<td align="left">22</td>
<td align="left">8.7</td>
<td align="left">1620</td>
<td align="left">13.3</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td rowspan="3" align="left">ASA</td>
<td align="left">I</td>
<td align="left">79</td>
<td align="left">31.2</td>
<td align="left">2722</td>
<td align="left">22.2</td>
<td align="left">&#x3c;0.001</td>
</tr>
<tr>
<td align="left">II</td>
<td align="left">145</td>
<td align="left">57.3</td>
<td align="left">7408</td>
<td align="left">60.5</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td align="left">III/IV</td>
<td align="left">29</td>
<td align="left">11.5</td>
<td align="left">2115</td>
<td align="left">17.3</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td rowspan="3" align="left">Defect size</td>
<td align="left">I (&#x3c;1.5&#xa0;cm)</td>
<td align="left">92</td>
<td align="left">36.4</td>
<td align="left">2461</td>
<td align="left">20.1</td>
<td align="left">&#x3c;0.001</td>
</tr>
<tr>
<td align="left">II (1.5&#x2013;3&#xa0;cm)</td>
<td align="left">129</td>
<td align="left">51.0</td>
<td align="left">6857</td>
<td align="left">56.0</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td align="left">III (&#x3e;3&#xa0;cm)</td>
<td align="left">32</td>
<td align="left">12.6</td>
<td align="left">2927</td>
<td align="left">23.9</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td rowspan="4" align="left">EHS classification</td>
<td align="left">Medial</td>
<td align="left">108</td>
<td align="left">42.7</td>
<td align="left">5537</td>
<td align="left">45.2</td>
<td align="left">0.008</td>
</tr>
<tr>
<td align="left">Lateral</td>
<td align="left">109</td>
<td align="left">43.1</td>
<td align="left">5235</td>
<td align="left">42.8</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td align="left">Femoral</td>
<td align="left">5</td>
<td align="left">2.0</td>
<td align="left">39</td>
<td align="left">0.3</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td align="left">Combined</td>
<td align="left">31</td>
<td align="left">12.3</td>
<td align="left">1434</td>
<td align="left">11.7</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td rowspan="3" align="left">Preoperative pain</td>
<td align="left">No</td>
<td align="left">50</td>
<td align="left">19.8</td>
<td align="left">3014</td>
<td align="left">24.6</td>
<td align="left">0.042</td>
</tr>
<tr>
<td align="left">Yes</td>
<td align="left">173</td>
<td align="left">68.4</td>
<td align="left">8223</td>
<td align="left">67.2</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td align="left">Unknown</td>
<td align="left">30</td>
<td align="left">11.9</td>
<td align="left">1008</td>
<td align="left">8.2</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td rowspan="3" align="left">Timepoint of recurrence</td>
<td align="left">&#x2264;2 years</td>
<td align="left">109</td>
<td align="left">43.1</td>
<td align="left">4895</td>
<td align="left">40.0</td>
<td align="left">0.364</td>
</tr>
<tr>
<td align="left">2&#x2013;10 years</td>
<td align="left">107</td>
<td align="left">42.3</td>
<td align="left">5164</td>
<td align="left">42.2</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td align="left">&#x3e;10 years</td>
<td align="left">37</td>
<td align="left">14.6</td>
<td align="left">2186</td>
<td align="left">17.9</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td rowspan="2" align="left">Risk factors - total</td>
<td align="left">Yes</td>
<td align="left">55</td>
<td align="left">21.7</td>
<td align="left">3944</td>
<td align="left">32.2</td>
<td align="left">&#x3c;0.001</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">198</td>
<td align="left">78.3</td>
<td align="left">8301</td>
<td align="left">67.8</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td rowspan="2" align="left">- COPD</td>
<td align="left">Yes</td>
<td align="left">13</td>
<td align="left">5.1</td>
<td align="left">662</td>
<td align="left">5.4</td>
<td align="left">1.000</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">240</td>
<td align="left">94.9</td>
<td align="left">11,583</td>
<td align="left">94.6</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td rowspan="2" align="left">- Diabetes</td>
<td align="left">Yes</td>
<td align="left">6</td>
<td align="left">2.4</td>
<td align="left">782</td>
<td align="left">6.4</td>
<td align="left">0.006</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">247</td>
<td align="left">97.6</td>
<td align="left">11,463</td>
<td align="left">93.6</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td rowspan="2" align="left">- Aortic aneurysm</td>
<td align="left">Yes</td>
<td align="left">0</td>
<td align="left">0</td>
<td align="left">71</td>
<td align="left">0.6</td>
<td align="left">0.407</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">253</td>
<td align="left">100</td>
<td align="left">12,174</td>
<td align="left">99.4</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td rowspan="2" align="left">- Immunosuppression</td>
<td align="left">Yes</td>
<td align="left">2</td>
<td align="left">0.8</td>
<td align="left">118</td>
<td align="left">1.0</td>
<td align="left">1.000</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">251</td>
<td align="left">99.2</td>
<td align="left">12,127</td>
<td align="left">99.0</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td rowspan="2" align="left">- Corticoids</td>
<td align="left">Yes</td>
<td align="left">2</td>
<td align="left">0.8</td>
<td align="left">117</td>
<td align="left">1.0</td>
<td align="left">1.000</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">251</td>
<td align="left">99.2</td>
<td align="left">12,128</td>
<td align="left">99.0</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td rowspan="2" align="left">- Smoking</td>
<td align="left">Yes</td>
<td align="left">19</td>
<td align="left">7.5</td>
<td align="left">1394</td>
<td align="left">11.4</td>
<td align="left">0.056</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">234</td>
<td align="left">92.5</td>
<td align="left">10,851</td>
<td align="left">88.6</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td rowspan="2" align="left">- Coagulopathy</td>
<td align="left">Yes</td>
<td align="left">1</td>
<td align="left">0.4</td>
<td align="left">180</td>
<td align="left">1.5</td>
<td align="left">0.277</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">252</td>
<td align="left">99.6</td>
<td align="left">12,065</td>
<td align="left">98.5</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td rowspan="2" align="left">- Antithrombotic medication</td>
<td align="left">Yes</td>
<td align="left">17</td>
<td align="left">6.7</td>
<td align="left">1273</td>
<td align="left">10.4</td>
<td align="left">0.060</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">236</td>
<td align="left">93.3</td>
<td align="left">10,972</td>
<td align="left">89.6</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td rowspan="2" align="left">- Anticoagulant medication</td>
<td align="left">Yes</td>
<td align="left">1</td>
<td align="left">0.4</td>
<td align="left">228</td>
<td align="left">1.9</td>
<td align="left">0.095</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">252</td>
<td align="left">99.6</td>
<td align="left">12,017</td>
<td align="left">98.1</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td rowspan="2" align="left">- Liver cirrhosis</td>
<td align="left">Yes</td>
<td align="left">0</td>
<td align="left">0</td>
<td align="left">15</td>
<td align="left">0.3</td>
<td align="left">1.000</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">77</td>
<td align="left">100</td>
<td align="left">4626</td>
<td align="left">99.7</td>
<td align="left">&#x200b;</td>
</tr>
<tr>
<td rowspan="2" align="left">- Anticoagulants</td>
<td align="left">Yes</td>
<td align="left">4</td>
<td align="left">5.2</td>
<td align="left">166</td>
<td align="left">3.6</td>
<td align="left">0.359</td>
</tr>
<tr>
<td align="left">No</td>
<td align="left">73</td>
<td align="left">94.8</td>
<td align="left">4475</td>
<td align="left">96.4</td>
<td align="left">&#x200b;</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3-3">
<title>Propensity score matching</title>
<p>Propensity score matching successfully identified 248 matched patient pairs for final analysis, corresponding to 98.0% of all patients who underwent Shouldice repair (<xref ref-type="sec" rid="s14">Supplementary Table S3</xref>).</p>
<p>Covariate balance improved substantially after matching (<xref ref-type="table" rid="T2">Table 2</xref>; <xref ref-type="fig" rid="F2">Figure 2</xref>). Standardized differences were below 0.10 for all matching variables, indicating good balance between the treatment groups and successful reduction of measured baseline confounding.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Standardized differences in continuous and categorical matching variables for Shouldice vs. Lichtenstein before and after matching.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="2" align="center">&#x200b;</th>
<th colspan="2" align="center">OP technique</th>
<th colspan="2" align="center">Standardized difference</th>
</tr>
<tr>
<th align="center">Variable</th>
<th align="center">Statistics</th>
<th align="center">Shouldice</th>
<th align="center">Lichtenstein</th>
<th align="center">Matched sample</th>
<th align="center">Original sample</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Age [years]</td>
<td align="left">Mean &#xb1; SD</td>
<td align="left">57.5 &#xb1; 16.0</td>
<td align="left">58.6 &#xb1; 14.8</td>
<td align="right">0.072</td>
<td align="right">0.327</td>
</tr>
<tr>
<td align="left">Male<sup>&#x2021;</sup>
</td>
<td align="left">N/%</td>
<td align="left">215/86.7</td>
<td align="left">215/86.7</td>
<td align="right">0</td>
<td align="right">0.374</td>
</tr>
<tr>
<td align="left">Underweight<sup>&#x2021;</sup>
</td>
<td align="left">N/%</td>
<td align="left">1/0.4</td>
<td align="left">1/0.4</td>
<td align="right">0</td>
<td align="right">&#x3c;0.001</td>
</tr>
<tr>
<td align="left">Normal weight<sup>&#x2021;</sup>
</td>
<td align="left">N/%</td>
<td align="left">126/50.8</td>
<td align="left">126/50.8</td>
<td align="right">0</td>
<td align="right">0.255</td>
</tr>
<tr>
<td align="left">Overweight<sup>&#x2021;</sup>
</td>
<td align="left">N/%</td>
<td align="left">100/40.3</td>
<td align="left">100/40.3</td>
<td align="right">0</td>
<td align="right">0.162</td>
</tr>
<tr>
<td align="left">Obesity/Morbid<sup>&#x2021;</sup>
</td>
<td align="left">N/%</td>
<td align="left">21/8.5</td>
<td align="left">21/8.5</td>
<td align="right">0</td>
<td align="right">0.146</td>
</tr>
<tr>
<td align="left">ASA score I</td>
<td align="left">N/%</td>
<td align="left">78/31.5</td>
<td align="left">80/32.3</td>
<td align="right">0.017</td>
<td align="right">0.204</td>
</tr>
<tr>
<td align="left">ASA score II</td>
<td align="left">N/%</td>
<td align="left">143/57.7</td>
<td align="left">138/55.6</td>
<td align="right">0.041</td>
<td align="right">0.065</td>
</tr>
<tr>
<td align="left">ASA score III-IV</td>
<td align="left">N/%</td>
<td align="left">27/10.9</td>
<td align="left">30/12.1</td>
<td align="right">0.038</td>
<td align="right">0.166</td>
</tr>
<tr>
<td align="left">Defect size I (&#x3c;1.5&#xa0;cm)<sup>&#x2021;</sup>
</td>
<td align="left">N/%</td>
<td align="left">88/35.5</td>
<td align="left">88/35.5</td>
<td align="right">0</td>
<td align="right">0.367</td>
</tr>
<tr>
<td align="left">Defect size II (1.5&#x2013;3&#xa0;cm)<sup>&#x2021;</sup>
</td>
<td align="left">N/%</td>
<td align="left">128/51.6</td>
<td align="left">128/51.6</td>
<td align="right">0</td>
<td align="right">0.101</td>
</tr>
<tr>
<td align="left">Defect size III (&#x3e;3&#xa0;cm)<sup>&#x2021;</sup>
</td>
<td align="left">N/%</td>
<td align="left">32/12.9</td>
<td align="left">32/12.9</td>
<td align="right">0</td>
<td align="right">0.294</td>
</tr>
<tr>
<td align="left">EHS medial</td>
<td align="left">N/%</td>
<td align="left">137/55.2</td>
<td align="left">143/57.7</td>
<td align="right">0.049</td>
<td align="right">0.037</td>
</tr>
<tr>
<td align="left">EHS lateral</td>
<td align="left">N/%</td>
<td align="left">137/55.2</td>
<td align="left">137/55.2</td>
<td align="right">0</td>
<td align="right">0.013</td>
</tr>
<tr>
<td align="left">EHS femoral</td>
<td align="left">N/%</td>
<td align="left">4/1.6</td>
<td align="left">5/2.0</td>
<td align="right">0.030</td>
<td align="right">0.139</td>
</tr>
<tr>
<td align="left">Preoperative pain</td>
<td align="left">N/%</td>
<td align="left">169/68.1</td>
<td align="left">172/69.4</td>
<td align="right">0.026</td>
<td align="right">0.026</td>
</tr>
<tr>
<td align="left">No preoperative pain</td>
<td align="left">N/%</td>
<td align="left">50/20.2</td>
<td align="left">47/19.0</td>
<td align="right">0.031</td>
<td align="right">0.117</td>
</tr>
<tr>
<td align="left">Unknown preoperative pain</td>
<td align="left">N/%</td>
<td align="left">29/11.7</td>
<td align="left">29/11.7</td>
<td align="right">0</td>
<td align="right">0.121</td>
</tr>
<tr>
<td align="left">Timepoint of recurrence (&#x3c;&#x3d;2 years)<sup>&#x2021;</sup>
</td>
<td align="left">N/%</td>
<td align="left">109/44.0</td>
<td align="left">109/44.0</td>
<td align="right">0</td>
<td align="right">0.063</td>
</tr>
<tr>
<td align="left">Timepoint of recurrence (2&#x2013;10 years)<sup>&#x2021;</sup>
</td>
<td align="left">N/%</td>
<td align="left">106/42.7</td>
<td align="left">106/42.7</td>
<td align="right">0</td>
<td align="right">0.002</td>
</tr>
<tr>
<td align="left">Timepoint of recurrence (&#x3e;10 years)<sup>&#x2021;</sup>
</td>
<td align="left">N/%</td>
<td align="left">33/13.3</td>
<td align="left">33/13.3</td>
<td align="right">0</td>
<td align="right">0.088</td>
</tr>
<tr>
<td align="left">COPD</td>
<td align="left">N/%</td>
<td align="left">12/4.8</td>
<td align="left">12/4.8</td>
<td align="right">0</td>
<td align="right">0.012</td>
</tr>
<tr>
<td align="left">Diabetes</td>
<td align="left">N/%</td>
<td align="left">5/2.0</td>
<td align="left">3/1.2</td>
<td align="right">0.064</td>
<td align="right">0.197</td>
</tr>
<tr>
<td align="left">Aortic aneurysm</td>
<td align="left">N/%</td>
<td align="left">0/0</td>
<td align="left">0/0</td>
<td align="right">-</td>
<td align="right">0.108</td>
</tr>
<tr>
<td align="left">Immunosuppression</td>
<td align="left">N/%</td>
<td align="left">2/0.8</td>
<td align="left">3/1.2</td>
<td align="right">0.040</td>
<td align="right">0.019</td>
</tr>
<tr>
<td align="left">Corticoids</td>
<td align="left">N/%</td>
<td align="left">2/0.8</td>
<td align="left">4/1.6</td>
<td align="right">0.074</td>
<td align="right">0.018</td>
</tr>
<tr>
<td align="left">Smoking</td>
<td align="left">N/%</td>
<td align="left">19/7.7</td>
<td align="left">18/7.3</td>
<td align="right">0.015</td>
<td align="right">0.133</td>
</tr>
<tr>
<td align="left">Coagulopathy</td>
<td align="left">N/%</td>
<td align="left">1/0.4</td>
<td align="left">0/0</td>
<td align="right">0.090</td>
<td align="right">0.112</td>
</tr>
<tr>
<td align="left">Antithrombotic medication</td>
<td align="left">N/%</td>
<td align="left">16/6.5</td>
<td align="left">17/6.9</td>
<td align="right">0.016</td>
<td align="right">0.132</td>
</tr>
<tr>
<td align="left">Anticoagulant medication</td>
<td align="left">N/%</td>
<td align="left">1/0.4</td>
<td align="left">1/0.4</td>
<td align="right">0</td>
<td align="right">0.139</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>
<sup>&#x2021;</sup>exact matching variables (same expression forced within a pair) EHS medial and EHS lateral include combined defects (counted in both categories).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Scatter plot - Standardized differences (before and after matching) when comparing Shouldice vs. Lichtenstein.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="jaws-05-17769-g002.tif">
<alt-text content-type="machine-generated">Dot plot comparing standardized differences for multiple patient variables, with open diamonds representing the original sample and black diamonds representing the matched sample. Most matched sample values cluster near zero, indicating improved balance compared to the original sample. Variables assessed include age, sex, BMI categories, ASA scores, defect size, EHS classification, preoperative pain status, timepoint of recurrence, COPD, diabetes, aortic aneurysm, immunosuppression, corticoid use, smoking, coagulopathy, and use of antithrombotic or anticoagulant medication. Legend distinguishes original versus matched samples.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-4">
<title>Matched outcome analysis</title>
<p>Perioperative and one-year outcomes of the matched cohort are summarized in <xref ref-type="table" rid="T3">Table 3</xref>, with corresponding odds ratios presented in <xref ref-type="fig" rid="F3">Figure 3</xref>.</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Summary of analysis results for systematic difference between the comparison groups, incl. odds ratio for paired samples (n&#x3d;248 paired operations).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">&#x200b;</th>
<th colspan="2" align="center">Concordant cases N (%)</th>
<th colspan="2" align="center">Discordant cases N (%)</th>
<th align="left">&#x200b;</th>
<th colspan="3" align="center">OR for matched samples</th>
</tr>
<tr>
<th align="center">Outcome variables</th>
<th align="center">Event in both patients</th>
<th align="center">No event in both patients</th>
<th align="center">Event in &#x27;shouldice&#x2019; only</th>
<th align="center">Event in &#x27;lichtenstein&#x2019; only</th>
<th align="center">p-Value</th>
<th align="center">OR</th>
<th align="center">Lower limit</th>
<th align="center">Upper limit</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Intraoperative complications<xref ref-type="table-fn" rid="Tfn1">&#x2a;</xref>
</td>
<td align="left">0 (0%)</td>
<td align="left">246 (99.2%)</td>
<td align="left">2 (0.8%)</td>
<td align="left">0 (0%)</td>
<td align="right">0.250</td>
<td align="right">2.414</td>
<td align="right">0.069</td>
<td align="right">-</td>
</tr>
<tr>
<td align="left">General complications<xref ref-type="table-fn" rid="Tfn1">&#x2a;</xref>
</td>
<td align="left">0 (0%)</td>
<td align="left">247 (99.6%)</td>
<td align="left">1 (0.4%)</td>
<td align="left">0 (0%)</td>
<td align="right">0.500</td>
<td align="right">1.000</td>
<td align="right">0.004</td>
<td align="right">-</td>
</tr>
<tr>
<td align="left">Postoperative complications</td>
<td align="left">0 (0%)</td>
<td align="left">231 (93.1%)</td>
<td align="left">8 (3.2%)</td>
<td align="left">9 (3.6%)</td>
<td align="right">1.000</td>
<td align="right">0.889</td>
<td align="right">0.182</td>
<td align="right">4.148</td>
</tr>
<tr>
<td align="left">Complication-related reoperations</td>
<td align="left">0 (0%)</td>
<td align="left">245 (98.8%)</td>
<td align="left">2 (0.8%)</td>
<td align="left">1 (0.4%)</td>
<td align="right">1.000</td>
<td align="right">2.000</td>
<td align="right">0.027</td>
<td align="right">1436.848</td>
</tr>
<tr>
<td align="left">Recurrence on 1-year follow-up</td>
<td align="left">1 (0.4%)</td>
<td align="left">236 (95.2%)</td>
<td align="left">5 (2.0%)</td>
<td align="left">6 (2.4%)</td>
<td align="right">1.000</td>
<td align="right">0.833</td>
<td align="right">0.104</td>
<td align="right">5.979</td>
</tr>
<tr>
<td align="left">Pain on exertion on 1-year follow-up</td>
<td align="left">13 (5.2%)</td>
<td align="left">148 (59.7%)</td>
<td align="left">33 (13.3%)</td>
<td align="left">54 (21.8%)</td>
<td align="right">0.031</td>
<td align="right">0.611</td>
<td align="right">0.310</td>
<td align="right">1.165</td>
</tr>
<tr>
<td align="left">Pain at rest on 1-year follow-up</td>
<td align="left">6 (2.4%)</td>
<td align="left">189 (76.2%)</td>
<td align="left">22 (8.9%)</td>
<td align="left">31 (12.5%)</td>
<td align="right">0.272</td>
<td align="right">0.710</td>
<td align="right">0.299</td>
<td align="right">1.624</td>
</tr>
<tr>
<td align="left">Pain requiring treatment on 1-year follow-up</td>
<td align="left">1 (0.4%)</td>
<td align="left">205 (82.7%)</td>
<td align="left">21 (8.5%)</td>
<td align="left">21 (8.5%)</td>
<td align="right">1.000</td>
<td align="right">1.000</td>
<td align="right">0.389</td>
<td align="right">2.569</td>
</tr>
<tr>
<td align="left">Trocar hernia on 1-year follow-up<xref ref-type="table-fn" rid="Tfn1">&#x2a;</xref>
</td>
<td align="left">0 (0%)</td>
<td align="left">247 (99.6%)</td>
<td align="left">1 (0.4%)</td>
<td align="left">0 (0%)</td>
<td align="right">0.500</td>
<td align="right">1.000</td>
<td align="right">0.004</td>
<td align="right">-</td>
</tr>
<tr>
<td align="left">Secondary hemorrhage on 1-year follow-up</td>
<td align="left">0 (0%)</td>
<td align="left">241 (97.2%)</td>
<td align="left">5 (2.0%)</td>
<td align="left">2 (0.8%)</td>
<td align="right">0.453</td>
<td align="right">2.500</td>
<td align="right">0.202</td>
<td align="right">97.675</td>
</tr>
<tr>
<td align="left">Seroma on 1-year follow-up</td>
<td align="left">0 (0%)</td>
<td align="left">233 (94.0%)</td>
<td align="left">6 (2.4%)</td>
<td align="left">9 (3.6%)</td>
<td align="right">0.607</td>
<td align="right">0.667</td>
<td align="right">0.109</td>
<td align="right">3.397</td>
</tr>
<tr>
<td align="left">Infection on 1-year follow-up</td>
<td align="left">0 (0%)</td>
<td align="left">242 (97.6%)</td>
<td align="left">4 (1.6%)</td>
<td align="left">2 (0.8%)</td>
<td align="right">0.687</td>
<td align="right">2.000</td>
<td align="right">0.129</td>
<td align="right">82.471</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn1">
<label>&#x2a;</label>
<p>Median unbiased estimate, one-sided p-value and one-sided CI.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Forest plot - odds ratios (incl. Bonferroni-adjusted confidence interval) for outcome parameters for Shouldice vs. Lichtenstein (n&#x3d;248 paired operations; outcomes with valid two-sided CI only).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="jaws-05-17769-g003.tif">
<alt-text content-type="machine-generated">Forest plot comparing odds ratios with adjusted confidence intervals for several postoperative outcomes between Shouldice and Lichtenstein techniques, showing point estimates and confidence intervals for complications, reoperations, recurrence, pain, hemorrhage, seroma, and infection.</alt-text>
</graphic>
</fig>
<p>No statistically significant differences were observed between Shouldice and Lichtenstein repair for any predefined outcome after Bonferroni correction. Specifically, rates of intraoperative complications, postoperative complications, general complications, complication-related reoperations, and one-year recurrence (2.4% vs. 2.8%; OR 0.83, adj. CI 0.10&#x2013;5.98), did not differ significantly between both procedures.</p>
<p>Similarly, no significant differences were detected for surgical-site complications on 1-year follow-up, including postoperative haemorrhage, seroma formation, surgical-site infection, or trocar-site hernia.</p>
<p>With respect to patient-reported outcomes, pain at rest and pain requiring treatment at 1&#xa0;year did not differ significantly between the groups. Pain on exertion was numerically less frequent after Shouldice repair than after Lichtenstein repair (18.5% vs. 27.0%; discordant pairs 33 vs. 54; OR 0.61, adj. CI 0.31&#x2013;1.17); however, this difference did not remain statistically significant after adjustment for multiple comparisons (unadj. <italic>P</italic>&#x3d;0.031).</p>
<p>Overall, no outcome parameter demonstrated a statistically significant advantage for either operative technique.</p>
</sec>
<sec id="s3-5">
<title>Analysis population versus excluded patients without 1-year follow-up data</title>
<p>According to the inclusion criteria, the analysis population with 1-year follow-up data comprised 12,498 patients (corresponding to a 1-year follow-up rate of 65.6%, i.e. 12,498 of 19,042 patients fulfilling all other inclusion criteria). Due to missing 1-year follow-up data, 6,544 patients were excluded (<xref ref-type="fig" rid="F1">Figure 1</xref>). To assess a possible selection bias in this regard, standardized differences between patients with and without 1-year follow-up data were calculated. Standardized differences of more than 10% were noted only for age, and smoking (<xref ref-type="sec" rid="s14">Supplementary Figure S1</xref>). Patients in the analysis population were, on average, 3.2 years older, and were less frequently smokers (11.3% vs. 15.1%). For all other variables, including the perioperative complication rates, standardized differences of less than 0.1 were found, which do not indicate any selection bias.</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>In this propensity score&#x2013;matched registry analysis, no statistically significant differences in perioperative and one-year outcomes were detected between Shouldice and Lichtenstein repair for first recurrent groin hernias following previous laparo-endoscopic repair. In particular, no significant differences were observed with respect to recurrence, perioperative complications, complication-related reoperations, surgical-site complications, or patient-reported pain outcomes after adjustment for multiple testing. Although pain on exertion occurred less frequently after Shouldice repair, this difference did not reach statistical significance after Bonferroni correction.</p>
<p>To our knowledge, this is the first propensity score&#x2013;matched registry study directly comparing Shouldice and Lichtenstein repair in patients with recurrent groin hernias after previous laparo-endoscopic repair. Consequently, direct comparisons with the existing literature are limited.</p>
<p>Most comparative studies have focused on primary inguinal hernias. A recent meta-analysis of 14 randomized controlled trials involving 2,784 patients reported higher recurrence rates after Shouldice repair than after Lichtenstein repair, although the overall recurrence rate following Shouldice repair remained low (4.2%), supporting its use in appropriately selected patients, while no significant difference in chronic postoperative pain was found [<xref ref-type="bibr" rid="B8">8</xref>]. In contrast, another meta-analysis found lower rates of chronic postoperative pain after Shouldice repair at the expense of a modest increase in long-term recurrence [<xref ref-type="bibr" rid="B9">9</xref>]. More recently, a propensity score&#x2013;matched registry analysis from the United States demonstrated comparable 30-day postoperative outcomes between both techniques while reporting reduced postoperative opioid requirements after Shouldice repair [<xref ref-type="bibr" rid="B14">14</xref>].</p>
<p>Current international guidelines recommend an anterior mesh-based repair, most commonly the Lichtenstein technique, for recurrent groin hernias following previous posterior repair [<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>]. This recommendation is primarily based on the principle of changing the surgical plane rather than on direct comparative evidence between tissue- and mesh-based anterior repairs. The present analysis provides initial comparative data on this question: in a carefully matched cohort, no statistically significant differences in short-term outcomes were detected between the two procedures, although clinically relevant differences cannot be excluded.</p>
<p>The pathogenesis of recurrent groin hernia is multifactorial and includes both technical and patient-related factors [<xref ref-type="bibr" rid="B15">15</xref>]. Following laparo-endoscopic repair, recurrence is frequently attributed to inadequate coverage of the myopectineal orifice, mesh displacement, shrinkage, or fixation failure [<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>]. In addition, laparo-endoscopic repair does not involve reconstruction of the inguinal canal, which could be a cause of recurrence, particularly in large lateral hernias. Early recurrence is generally considered to reflect technical failure, whereas late recurrence is more likely related to impaired tissue quality and biological predisposition [<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>]. In the present cohort, the recurrence under investigation had occurred within 2&#xa0;years after the index laparo-endoscopic repair in more than 40% of patients (<xref ref-type="table" rid="T1">Table 1</xref>). This baseline variable describes only the interval between the index operation and the recurrence treated in this study and is not an outcome of the present analysis; nevertheless, it may suggest that technical factors contributed in a substantial proportion of patients.</p>
<p>The increasing use of laparo-endoscopic techniques for primary groin hernia repair inevitably results in a growing number of patients presenting with recurrence after previous posterior mesh implantation. In this setting, implantation of an additional anterior mesh may not always be desirable. Tissue-based repair may therefore represent an attractive alternative in carefully selected patients, particularly when avoidance of additional prosthetic material is preferred. A further potential advantage of the Shouldice technique may arise in the event of a re-recurrence, as subsequent anterior mesh implantation may be technically easier in a previously mesh-free anterior field. Long-term studies have demonstrated durable results after standardized Shouldice repair, and contemporary international guidelines continue to recommend the Shouldice technique as the preferred non-mesh repair whenever a tissue-based approach is indicated [<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B10">10</xref>&#x2013;<xref ref-type="bibr" rid="B12">12</xref>]. Our findings support this concept by showing no statistically significant difference in perioperative safety or short-term recurrence between Shouldice and Lichtenstein repair; as this study was not designed or powered as a formal non-inferiority comparison and several outcome estimates have wide confidence intervals, these results should be interpreted as reassuring rather than as definitive evidence of equivalence.</p>
</sec>
<sec id="s5">
<title>Limitations</title>
<p>The strengths of this study include the use of a large multicentre prospective registry and rigorous propensity score matching, which resulted in excellent covariate balance between treatment groups. Nevertheless, several limitations should be acknowledged. First, only a small proportion of patients underwent Shouldice repair, reflecting current clinical practice and limiting statistical power. The low proportion of Shouldice repairs (2.0%) suggests that the technique is used selectively, probably by surgeons and centres with particular expertise, which may limit the transferability of the results to routine practice. No <italic>a priori</italic> sample size calculation or predefined clinically relevant difference was used. In addition, we checked whether the selected patient group with a complete 1-year follow-up is also representative of all patients without a complete follow-up (<xref ref-type="sec" rid="s14">Supplementary Figure S1</xref>). Standardized differences above the guideline value of 10% can be found for age and smoking. The patients in the analysis population are on average 3.2 years older and have a lower proportion of smokers. In our view, there is no clear clinical relevance to this. For all other variables, including further perioperative complication rates, there are standardized differences of less than 0.1 and only very small descriptive differences, which thus do not indicate relevant biases in patient selection.</p>
<p>Second, although propensity score matching reduced measured confounding, residual as well as unobserved confounding inherent to observational registry studies cannot be excluded. In particular, surgeon- and centre-related factors, such as individual experience with the Shouldice technique or institutional volume, could not be included in the matching and may represent residual confounding.</p>
<p>Third, follow-up was limited to 1&#xa0;year. Because recurrent groin hernias may occur many years after surgery, meaningful conclusions regarding long-term recurrence and chronic pain cannot yet be drawn.</p>
<p>Fourth, this study was not designed as a formal non-inferiority trial; confidence intervals for several outcomes, particularly rarer events such as recurrence and complication-related reoperation, were wide, and the absence of a statistically significant difference should not be interpreted as proof of equivalence between the two techniques.</p>
<p>Fifth, participation in the Herniamed Registry is voluntary. Although numerous institutions in Germany, Austria and Switzerland contribute data, the proportion of all groin hernia repairs captured in these countries is unknown, and participating institutions may differ from non-participating ones. In addition, the small number of selectively performed Shouldice repairs may limit the representativeness of the matched cohort. The results should therefore not be generalized uncritically to all patients undergoing repair of recurrent groin hernia.</p>
</sec>
<sec sec-type="conclusion" id="s6">
<title>Conclusion</title>
<p>In carefully selected patients with first recurrent groin hernia following previous laparo-endoscopic repair, Shouldice repair showed perioperative safety and one-year outcomes not significantly different from those of guideline-recommended Lichtenstein repair. These findings suggest that, when performed by experienced surgeons, the Shouldice technique may represent a valuable mesh-free alternative in this clinical setting. Given the limited sample size and wide confidence intervals, clinically relevant differences cannot be excluded. Confirmation by larger studies with long-term follow-up is warranted before broader recommendations can be made.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s7">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s14">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="ethics-statement" id="s8">
<title>Ethics statement</title>
<p>The studies of the Herniamed Registry involving human participants were reviewed and approved by Ethics Committee Kanton St. Gallen (BASEC Nr. 2016-00123), Ethics Committee University of T&#xfc;bingen (287/2017 BO2), Ethics Committee State Medical Association Baden-W&#xfc;rttemberg (F-2022-111), and Ethic Committee University of Cologne (24-1115-retro). The patients/participants provided written informed consent to participate in this study.</p>
</sec>
<sec sec-type="author-contributions" id="s9">
<title>Author contributions</title>
<p>All authors (RL, SA, JC, RF, KK, AK, FK, FM, HP, HR, MW, MH, and RW) participated in the design, interpretation of the studies and analysis of the data and review of the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec sec-type="COI-statement" id="s11">
<title>Conflict of interest</title>
<p>Author MH was employed by StatConsult GmbH.</p>
<p>The remaining author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s12">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was used in the creation of this manuscript. AI-assisted language editing Chat GPT was used exclusively to improve linguistic clarity. The authors accept full responsibility for the accuracy and integrity of the manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="s13">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="s14">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontierspartnerships.org/articles/10.3389/jaws.2026.17769/full#supplementary-material">https://www.frontierspartnerships.org/articles/10.3389/jaws.2026.17769/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table1.pdf" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table2.pdf" id="SM2" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table3.pdf" id="SM3" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="DataSheet1.pdf" id="SM4" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arias-Espinosa</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Milky</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bossie</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Barrocas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Atchison</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shih</surname>
<given-names>IF</given-names>
</name>
<etal/>
</person-group> <article-title>Metachronous reoperation for recurrent and non-recurrent inguinal hernia after primary unilateral inguinal hernia repair: propensity score matched analysis of large US claims database</article-title>. <source>Hernia</source> (<year>2025</year>) <volume>30</volume>(<issue>1</issue>):<fpage>25</fpage>. <pub-id pub-id-type="doi">10.1007/s10029-025-03518-1</pub-id>
<pub-id pub-id-type="pmid">41317213</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nikkolo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lillsaar</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Vaasna</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kirsim&#xe4;gi</surname>
<given-names>&#xdc;</given-names>
</name>
<name>
<surname>Lepner</surname>
<given-names>U</given-names>
</name>
</person-group>. <article-title>Ten-year results of inguinal hernia open mesh repair</article-title>. <source>J Abdom Wall Surg</source> (<year>2025</year>) <volume>4</volume>:<fpage>14384</fpage>. <pub-id pub-id-type="doi">10.3389/jaws.2025.14384</pub-id>
<pub-id pub-id-type="pmid">40551961</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<label>3.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murphy</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Ubl</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Habermann</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Farley</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Paley</surname>
<given-names>K</given-names>
</name>
</person-group>. <article-title>Trends of inguinal hernia repairs performed for recurrence in the United States</article-title>. <source>Surgery</source> (<year>2018</year>) <volume>163</volume>(<issue>2</issue>):<fpage>343</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/j.surg.2017.08.001</pub-id>
<pub-id pub-id-type="pmid">28923698</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<label>4.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>K&#xf6;ckerling</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Kr&#xfc;ger</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gagarkin</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Kuthe</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Adolf</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Stechemesser</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group> <article-title>What is the outcome of re-recurrent vs recurrent inguinal hernia repairs? An analysis of 16,206 patients from the herniamed registry</article-title>. <source>Hernia</source> (<year>2020</year>) <volume>24</volume>(<issue>4</issue>):<fpage>811</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1007/s10029-020-02138-1</pub-id>
<pub-id pub-id-type="pmid">32086633</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<label>5.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>K&#xf6;ckerling</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Koch</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lorenz</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schug-Pass</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Stechemesser</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Reinpold</surname>
<given-names>W</given-names>
</name>
</person-group>. <article-title>How long do we need to Follow-Up our hernia patients to find the real recurrence rate?</article-title> <source>Front Surg</source> (<year>2015</year>) <volume>2</volume>:<fpage>24</fpage>. <pub-id pub-id-type="doi">10.3389/fsurg.2015.00024</pub-id>
<pub-id pub-id-type="pmid">26137464</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<label>6.</label>
<mixed-citation publication-type="journal">
<collab>HerniaSurge Group</collab>. <article-title>International guidelines for groin hernia management</article-title>. <source>Hernia</source> (<year>2018</year>) <volume>22</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1007/s10029-017-1668-x</pub-id>
<pub-id pub-id-type="pmid">29330835</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<label>7.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stabilini</surname>
<given-names>C</given-names>
</name>
<name>
<surname>van Veenendaal</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Aasvang</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Agresta</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Aufenacker</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Berrevoet</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group> <article-title>Update of the international HerniaSurge guidelines for groin hernia management</article-title>. <source>BJS Open</source> (<year>2023</year>) <volume>7</volume>(<issue>5</issue>):<fpage>zrad080</fpage>. <pub-id pub-id-type="doi">10.1093/bjsopen/zrad080</pub-id>
<pub-id pub-id-type="pmid">37862616</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<label>8.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pompeu</surname>
<given-names>BF</given-names>
</name>
<name>
<surname>Pasqualotto</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Marcolin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Delgado</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Pigossi</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Leme</surname>
<given-names>LFP</given-names>
</name>
<etal/>
</person-group> <article-title>Shouldice <italic>versus</italic> lichtenstein inguinal hernia repair: a meta-analysis of randomized controlled trials</article-title>. <source>World J Surg</source> (<year>2024</year>) <volume>48</volume>(<issue>11</issue>):<fpage>2604</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1002/wjs.12352</pub-id>
<pub-id pub-id-type="pmid">39289161</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<label>9.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva Carvalho</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Muricy</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Habib</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Barros</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>de Lima</surname>
<given-names>MLA</given-names>
</name>
</person-group>. <article-title>Chronic pain after shouldice <italic>versus</italic> lichtenstein inguinal hernia repair: a systematic review and meta-analysis</article-title>. <source>Hernia</source> (<year>2026</year>) <volume>30</volume>(<issue>1</issue>):<fpage>213</fpage>. <pub-id pub-id-type="doi">10.1007/s10029-026-03702-x</pub-id>
<pub-id pub-id-type="pmid">42118350</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<label>10.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amato</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Moja</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Panico</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Persico</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rispoli</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rocco</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group> <article-title>Shouldice technique <italic>versus</italic> other open techniques for inguinal hernia repair</article-title>. <source>Cochrane Database Syst Rev</source> (<year>2012</year>) <volume>2012</volume>(<issue>4</issue>):<fpage>CD001543</fpage>. <pub-id pub-id-type="doi">10.1002/14651858.CD001543.pub4</pub-id>
<pub-id pub-id-type="pmid">22513902</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<label>11.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lorenz</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Arlt</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Conze</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fortelny</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gorjanc</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Koch</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>Shouldice standard 2020: review of the current literature and results of an international consensus meeting</article-title>. <source>Hernia</source> (<year>2021</year>) <volume>25</volume>(<issue>5</issue>):<fpage>1199</fpage>&#x2013;<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1007/s10029-020-02365-6</pub-id>
<pub-id pub-id-type="pmid">33502639</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<label>12.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mainprize</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Spencer Netto</surname>
<given-names>FAC</given-names>
</name>
<name>
<surname>Degani</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Szasz</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>The shouldice method: an expert&#x27;s consensus</article-title>. <source>Hernia</source> (<year>2023</year>) <volume>27</volume>(<issue>1</issue>):<fpage>147</fpage>&#x2013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1007/s10029-022-02658-y</pub-id>
<pub-id pub-id-type="pmid">35939246</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<label>13.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stechemesser</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Jacob</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Schug-Pa&#xdf;</surname>
<given-names>C</given-names>
</name>
<name>
<surname>K&#xf6;ckerling</surname>
<given-names>F</given-names>
</name>
</person-group>. <article-title>Herniamed: an internet-based registry for outcome research in hernia surgery</article-title>. <source>Hernia</source> (<year>2012</year>) <volume>16</volume>(<issue>3</issue>):<fpage>269</fpage>&#x2013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1007/s10029-012-0908-3</pub-id>
<pub-id pub-id-type="pmid">22389073</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<label>14.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ellis</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Maskal</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Petro</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Krpata</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Prabhu</surname>
<given-names>AS</given-names>
</name>
<etal/>
</person-group> <article-title>Shouldice vs lichtenstein inguinal hernia repair: a propensity score-matched analysis comparing early postoperative pain and quality of life</article-title>. <source>J Am Coll Surg</source> (<year>2025</year>) <volume>241</volume>(<issue>5</issue>):<fpage>805</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1097/XCS.0000000000001548</pub-id>
<pub-id pub-id-type="pmid">40833054</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<label>15.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burcharth</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>The epidemiology and risk factors for recurrence after inguinal hernia surgery</article-title>. <source>Dan Med J</source> (<year>2014</year>) <volume>61</volume>(<issue>5</issue>):<fpage>B4846</fpage>.<pub-id pub-id-type="pmid">24814748</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<label>16.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>K&#xf6;ckerling</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Schug-Pass</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>Diagnostic laparoscopy as decision tool for Re-recurrent inguinal hernia treatment following open anterior and laparo-Endoscopic posterior repair</article-title>. <source>Front Surg</source> (<year>2017</year>) <volume>4</volume>:<fpage>22</fpage>. <pub-id pub-id-type="doi">10.3389/fsurg.2017.00022</pub-id>
<pub-id pub-id-type="pmid">28507989</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<label>17.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
</person-group>. <article-title>Analysis of mesh-related factors associated with recurrence and treatment outcomes after laparoscopic inguinal hernia repair</article-title>. <source>Surg Endosc</source> (<year>2025</year>) <volume>39</volume>(<issue>12</issue>):<fpage>8073</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1007/s00464-025-12209-y</pub-id>
<pub-id pub-id-type="pmid">40944740</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<label>18.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niebuhr</surname>
<given-names>H</given-names>
</name>
<name>
<surname>K&#xf6;ckerling</surname>
<given-names>F</given-names>
</name>
</person-group>. <article-title>Surgical risk factors for recurrence in inguinal hernia repair - a review of the literature</article-title>. <source>Innov Surg Sci</source> (<year>2017</year>) <volume>2</volume>(<issue>2</issue>):<fpage>53</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1515/iss-2017-0013</pub-id>
<pub-id pub-id-type="pmid">31579737</pub-id>
</mixed-citation>
</ref>
<ref id="B19">
<label>19.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>YS</given-names>
</name>
<etal/>
</person-group> <article-title>Retrospective study on prevalence of recurrent inguinal hernia: a large-scale multi-institutional study</article-title>. <source>Ann Surg Treat Res</source> (<year>2020</year>) <volume>98</volume>(<issue>1</issue>):<fpage>51</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.4174/astr.2020.98.1.51</pub-id>
<pub-id pub-id-type="pmid">31909050</pub-id>
</mixed-citation>
</ref>
</ref-list>
</back>
</article>